Abstract
NITRIC oxide (NO), a potent vasodilator produced by endothelial cells, is thought to be the endothelium-dependent relaxing factor (EDRF) which mediates vascular relaxation in response to acetylcholine, bradykinin and substance P in many vascular beds1-6. NO has been implicated in the regulation of blood pressure and regional blood flow4-6, and also affects vascular smooth-muscle prolifera-tion and inhibits platelet aggregation and leukocyte adhesion. Abnormalities in endothelial production of NO occur in atherosclerosis, diabetes and hypertension7. Pharmacological blockade of NO production with arginine analogues such as i -nitroarginine (L-NA) or L-N-arginine methyl ester affects multiple isoforms of nitric oxide synthase (NOS), and so cannot distinguish their physiological roles8,9. To study the role of endothelial NOS (eNOS) in vascular function, we disrupted the gene encoding eNOS in mice. Endothelium-derived relaxing factor activity, as assayed by acetylcholine-induced relaxation, is absent, and the eNOS mutant mice are hypertensive. Thus eNOS mediates basal vasodilation. Responses to NOS blockade in the mutant mice suggest that non-endothelial isoforms of NOS may be involved in maintaining blood pressure.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Palmer, R. M., Ferrige, A. G. & Moncada, S. Nature 327, 524–526 (1987).
Snyder, S. H. Nature 372, 504–505 (1994).
Bredt, D. S. & Snyder, S. H. A. Rev. Biochem. 63, 175–195 (1994).
Furchgott, R. F. in Mechanisms of Vasodilatation (ed. Vanhoutte, P. M.) 401–414 (Raven, New York. 1988).
Ignarro, L. J., Buga, G. M., Wood, K. S., Byrnes, R. E. & Chaudhuri, G. Proc. natn. Acad. Sci. U.S.A. 84, 9265–9269 (1987).
Rees, D. D., Palmer, R. M. & Mocada, S. Proc. natn. Acad. Sci. U.S.A. 86, 3375–3378 (1989).
Moncada, S. & Higgs, A. New Engl. J. Med. 329, 2002–2012 (1993).
Rees, D. D., Palmer, R. M., Schultz, R., Hodson, H. F. & Moncada, S. Br. J. Pharmac. 101, 746–752 (1990).
Marletta, M. A. Cell 78, 927–930 (1994).
Hevel, J. M. & Marletta, M. A. Methods Enzym. 233, 250–258 (1994).
Forstermann, U., Pollack, J. S., Tracey, W. R. & Nakane, M. Meth. Enzym. 233, 258–264 (1994).
Huang, P. L., Dawson, T. M., Bredt, D., Snyder, S. H. & Fishman, M. C. Cell 75, 1273–1286 (1993).
Irikura, K. et al. Proc. natn. Acad. Sci. U.S.A. 92, 6823–6827 (1995).
Sakuma, I. et al. Circulation Res. 70, 607–611 (1992).
Vincent, S. R. & Kimura, H. Neuroscience 46, 755–783 (1992).
Iadecola, C., Faris, P. L., Hartman, B. K. & Xu, X. Brain Res. 603, 173–179 (1993).
Anderson, C. R. Neurosci. Lett. 139, 280–284 (1992).
Toda, N., Ayajiki, K. & Okamura, T. J. vasc. Res. 30, 61–67 (1993).
Ayajiki, K., Okamura, T. & Toda, N. Neuroscience 54, 819–825 (1993).
Togashi, H. et al. J. Pharmac. exp. Ther. 262, 343–347 (1992).
Huang, Z. et al. Science 265, 1883–1885 (1994).
Frey, C. et al. J, biol. Chem. 269, 26083–26091 (1994).
Gardiner, S. M., Kemp, P. A., Bennett, T., Palmer, R. M. & Moncada, S. Eur. J. Pharmac. 213, 449–451 (1992).
Peart, W. S. in Hypertension 2nd edn (ed. Genest, J., Kuchel, O., Hamet, P. & Cantin, M.) (McGraw-Hall, New York, 1983).
Scrogin, K. E., Veelken, R. & Luft F. C. Hypertension 23, (2) 982–986 (1994).
Matsuda, T., Bates, J. N., Lewis, S. J., Abboud, F. M. & Chapleau, M. W. Circulation Res. 76, 426–433 (1995).
Da Silva, S. V., Da Silva, V. J., Ballejo, G., Salgado, M. C. O. & Slagado, H. C. Hypertension 23 (suppl.) 60–63 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Huang, P., Huang, Z., Mashimo, H. et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377, 239–242 (1995). https://doi.org/10.1038/377239a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/377239a0
This article is cited by
-
Signaling pathways in vascular function and hypertension: molecular mechanisms and therapeutic interventions
Signal Transduction and Targeted Therapy (2023)
-
Endothelial ILK induces cardioprotection by preventing coronary microvascular dysfunction and endothelial-to-mesenchymal transition
Basic Research in Cardiology (2023)
-
Urinary excretion of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine is positively related to nitric oxide level in tissues of normotensive and hypertensive rats
Amino Acids (2023)
-
The Clinical Value of Rodent Models in Understanding Preeclampsia Development and Progression
Current Hypertension Reports (2023)
-
Inhaled nitric oxide: role in the pathophysiology of cardio-cerebrovascular and respiratory diseases
Intensive Care Medicine Experimental (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.